¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ehrlich's neutral stain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® Gram stain ÇÑ±Û ±×¶÷¿°»ö
¼³¸í   
  ¹Ì»ý¹°À» ¿°»öÇϴ ¹æ¹ý ÁßÀÇ Çϳª. 1884³â µ§¸¶Å©ÀÇ ÀÇ»ç H.C.J. ±×¶÷(1853~ 1938)ÀÌ °í¾ÈÇѠƯ¼ö ¿°»ö¹ýÀÌ´Ù. ÀÌ ¿°»ö¹ýÀ» »ç¿ëÇϸ頹̻ý¹°Àº ¾ç¼º±Õ°ú À½¼º±ÕÀÇ 2¹«¸®·Î Å©°Ô ³ª´¶´Ù. ¿°»ö¹ýÀº ±ÕÀ» À¯¸®¸é¿¡ ¹Ù¸£°í °¡¿­ °íÁ¤ÇÑ´Ù. Á¨½Ã¾È¹ÙÀÌ¿À·¿, Å©¸®½ºÅ» ¹ÙÀÌ¿À·¿, ¸ÞÆ¿¹ÙÀÌ¿À·¿ µî ÆÄ¶ó·ÎÁƴҸ°°è »ö¼ÒÀÇ ¾î´À Çϳª¸¦ »ç¿ëÇÏ¿© ¿ì¼± ¿°»öÇϰí À̾ ·ç°ñ¾×À» ÀÛ¿ë½ÃŲ µÚ, ¿¡Åº¿Ã ¶Ç´Â ¾Æ¼¼ÅæÀ¸·Î Å»»öÇÑ´Ù. À̶§ Å»»öµÇÁö ¾Ê°í º¸¶ó»öÀ» Å¸³ª³»´Â °ÍÀ» ±×¶÷¾ç¼º±ÕÀ̶ó ºÎ¸£¸ç, Æ÷µµ¾Ë±Õ-Æó·Å¾Ë±Õ-»ç½½¾Ë±Õ µîÀÌ ´ëÇ¥ÀûÀΠ¿¹ÀÌ´Ù. Å»»öµÇ¸é ±×¶÷À½¼º±ÕÀ̶ó ºÎ¸£¸ç, ´ëÀå±Õ-³ì³ó±Õ µîÀÌ ÀÖ´Ù. ÃÖÈÄ¿¡ »çÇÁ¶ó´Ñ, Ç«½Å µî Àû»ö°èÀÇ »ö¼Ò¾×À¸·Î ÈÄ¿°»öÀ» ÇÑ´Ù. ¹Ì»ý¹°ÀÇ °¨º°¿¡ Áß¿äÇÑ ¿°»ö¹ýÀ̸砿°»ö¼ºÀÇ Â÷À̴ ¿µ¾ç¿ä±¸¼º, È­Çпä¹ýÁ¦(Ç×»ý¹°Áú µî)¿¡ ´ëÇÑ °¨¼ö¼ºÀÇ Â÷À̿͵µ °ü·ÃµÇ´Â Á¡ÀÌ ¸¹À¸¹Ç·Î »ç¿ë¾àÁ¦ÀÇ ¼±Åýÿ¡µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. ±×¶÷¾ç¼º±Õ°ú À½¼º±ÕÀÇ Â÷À̴ ¼¼±Õº®ÀÇ ±¸Á¶¿¡ Àִµ¥, ¾ç¼º±ÕÀº ¼¼Æ÷¸·ÀÇ ¹Ù±ùÂÊ ÆéƼµå±Û¸®Ä­À̶ó´Â ´ç´Ü¹éÁúÃþÀÇ µÎ²²°¡ 20~80nm³ª µÇ°í, ±×·¥À½¼º±ÕÀÇ ÆéƼµå±Û¸®Ä­ ÃþÀº 2~3nm·Î ¾ã°í, ´Ù½Ã ¹Ù±ùÂÊ¿¡ ¿Ü¸·À̶ó ºÎ¸£´Â ÃþÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neutral stain
    Áß¼º¿°»ö
  • neutral fat
    Áß¼ºÁö¹æ
  • neutral occlusion
    Á¤»ó¸Â¹°¸², Á¤»ó±³ÇÕ
  • neutral reaction
    Áß¼º¹ÝÀÀ, ÁßÈ­¹ÝÀÀ
  • neutral salt
    Áß¼º¿°
  • neutral zone
    Ç׿øÇ×üÆòÇü±¸¿ª
  • acid-fast stain
    Ç׻꿰»ö
  • basic stain
    ¿°±â¿°»ö
  • biological stain
    »ý¹°ÇÐÀû¿°»ö
  • contrast stain
    ´ëÁ¶¿°»ö
  • counter stain
    ´ëÁ¶¿°»ö
  • differential stain
    °¨º°¿°»ö
  • double stain
    ÀÌÁß¿°»ö
  • electron stain
    ÀüÀÚ¿°»ö
  • Gomori methenamine-silver stain
    °í¸ð¸®¸ÞÅ׳ª¹ÎÀº¿°»ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • stain
    ¿°»ö, ¿°·á, Âø»ö
  • acid-fast stain
    Ç׻꿰»ö
  • Gram stain
    ±×¶÷¿°»ö
  • silver stain
    Àº¿°»ö
  • Ziehl-Neelsen stain
    Ä¥³Ú¼¾¿°»ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neutral fat
    Áß¼ºÁö¹æ
  • neutral hermaphroditism
    Áß¼º³²³àÇѸöÁõ
  • neutral occlusion
    Á¤»ó¸Â¹°¸², Á¤»ó±³ÇÕ
  • neutral reaction
    ÁßÈ­¹ÝÀÀ
  • neutral salt
    Áß¼º¿°
  • neutral zone
    Ç׿øÇ×üÆòÇü±¸¿ª
  • acid-fast stain
    Ç׻꿰»ö
  • basic stain
    ¿°±â¿°»ö
  • biological stain
    »ý¹°ÇÐÀû¿°»ö
  • contrast stain
    ´ëÁ¶¿°»ö
  • counter stain
    (¢¡counterstain) ´ëÁ¶¿°»ö
  • differential stain
    ºÐº°¿°»ö
  • electron stain
    ÀüÀÚ¿°»ö
  • fluorescent antibody stain
    Çü±¤Ç×ü¿°»ö
  • Gram stain
    ±×¶÷¿°»ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Dorfman-Chanarin syndrome = neutral lipid storage disease
    Áß¼ºÁö¹æÃàÀûÁõ
  • Ehrlich reaction
    ¿¡¸£¸®È÷ ¹ÝÀÀ
  • Alician blue stain
    ¾Ë¸®¼¢ ºí·ç ¿°»ö
  • Congo red stain
    Äá°í·¹µå ¿°»ö(æøßä)
  • Hansel secretion stain
    ÇѼ¿ºÐºñ¹°¿°»ö
  • Heidenhain s iron hematoxylin stain
    ÇÏÀ̵§ÇÏÀΠö Ç츶Åå½Ç¸° ¿°»ö¹ý.
  • India ink stain
    Àεð¾ð À×Å© ¿°»ö
  • Kinyoun stain
    Ű³â¿°»ö
  • Nissls stain
    ´Ï½½¿°»ö.
  • PAS stain
    PAS ¿°»ö
  • PAS stain[ing]
    PAS¿°»ö(¹ý)
  • Papanicolaou stain
    ÆÄÆÄ´ÏÄݷο°»ö
  • Romanowsky stain
    ·Î¸¶³ëÇÁ½ºÅ°¿°»ö
  • Sudan black B stain
    ¼ö´Üºí·¢ B ¿°»ö
  • Verhoeff Van Gieson stain
    º£¸£È¸ÇÁ ¹Ý ±â½¼ ¿°»ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neutral
    Áß¼º(ñéàõ)ÀÇ, ÁßÈ­(ñéûú)ÀÇ.
  • neutral acriflavine
    Áß¼º¾ÆÅ©¸®Çöóºó.
  • neutral bath
    ¹Ì¿Â(ÅÁ)¿å(Ú°è®÷·é±).
  • neutral bath
    ¹Ì¿ÂÅÁ¿å(Ú°è®÷·é±)
  • neutral density filter
    Áß¼ºÇÊÅÍ
  • neutral fat
    Áß¼ºÁö¹æ(~ò·Û¸).
  • neutral flavin
    Áß¼ºÇöóºó.
  • neutral hermaphroditism
    Áß¼º¹ÝÀ½¾ç(Áõ) (~ÚâëäåÕñø).
  • neutral occlusion =normal o.
    Á¤»ó±³ÇÕ.
  • neutral oxide
    Áß¼º»êÈ­¹°(~ß«ûùÚª).
  • neutral point
    ÁßÈ­Á¡(ñéûúïÇ).
  • neutral point
    ÁßÈ­Á¡
  • neutral principle
    Áß¼º¼ººÐ.
  • neutral protease
  • neutral reaction
    ÁßÈ­¹ÝÀÀ(~Úãëë).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Diff-Quik stain
    µðÅ¥¿°»ö
  • Giemsa stain
    ±èÀÚ¿°»ö
  • iodine stain
    ¿ä¿Àµå¿°»ö
  • iron-hematoxylin stain
    öÇ츶Åå½Ç¸°¿°»ö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lipophilic stain
    Ä£ÁöÁú¼º(öÑò·òõàõ) ¿°»ö(æøßä)
  • vital stain
    »ý¿°»ö(ßææøßä)
  • Ehrlich ascites tumor
    ¿¡¸¦¸®È÷ º¹¼öÁ¾(ÜÙâ©ðþ)
  • Ehrlich reaction
    ¿¡¸¦¸®È÷ ¹ÝÀÀ(Úãëë)
  • Ehrlich's reagent
    ¿¡¸¦¸®È÷ ½Ã¾à(ãËå·)
  • Ehrlich's receptor theory
    ¿¡¸¦¸®È÷ ¼ö¿ëüÀÌ·Ð(áôé»ô÷×âÖå)
  • calcium-activated neutral proteinase
    Ä®½·ºÎȰ(Ý·üÀ) Áß¼º(ñéàõ)ÇÁ·ÎƼ³×À̽º
  • coupled neutral pump
    °ø¿ª(Íëæµ) ÁßÈ­(ñéûú) ÆßÇÁ
  • neutral amino acid
    Áß¼º(ñéàõ) ¾Æ¹Ì³ë»ê(ß«)
  • neutral fat
    Áß¼ºÁö¹æ(ñéàõò·Û¸)
  • neutral glycolipids
    Áß¼º´çÁöÁú(ñéàõÓØò·òõ)
  • neutral lipid
    Áß¼ºÁöÁú(ñéàõò·òõ)
  • neutral mutation
    Á߸³º¯ÀÌ(ñ騡܍ì¶)
  • neutral sugar
    Áß¼º ´ç(ñéàõÓØ)
  • neutral theory of molecular evolution
    Á߸³ºÐÀÚÁøÈ­·Ð(ñ騡ÝÂí­òäûùÖå)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neutral
    Áß¼ºÀÇ, ÁßÈ­ÀÇ
  • gram's stain
    ±×¶÷ ¿°»ö
  • tumor stain
    Á¾¾ç¿°»ö, Á¾¾çÁ¶¿µ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AFB Stain Acid Fast Bacilli Stain
HE stain Hematoxylin-Eosin stain
WS Waardenburg syndrome; ward secretary; Warkany syndrome; Warthin-Starry [stain]; water soluble; water...
EAC Ehrlich ascites carcinoma; electroacupuncture; epithelioma adenoides cysticum; erythema annulare cen...
EAT Eating Attitudes Test; Ehrlich ascites tumor; electro-aerosol therapy; epidermolysis acuta toxica; e...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PWS Port Wine Stain
EA Ehrlich Ascites
EAC Ehrlich Ascites Carcinoma
EAT Ehrlich Ascites Tumor
EATC Ehrlich Ascites tumour cells
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Ehrlich`s side chain theory
    ¿¡¸¦¸®È÷ÀÇ Ãø¼â¼³
    Ç×ü »ý»ê ±âÀü¿¡ ´ëÇÏ¿© Á¦¾ÈµÈ °¡¼³ÀÇ Çϳª. ¸ðµç ü ¼¼Æ÷ Ç¥¸é¿¡´Â Ãø¼â¶ó°í ÇÏ´Â ¼ö¿ëü°¡ ÀÖ°í, À̰Ϳ¡ ´ëÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇϸé Ȱ¼ºÈ­ µÇ°í, Ãø¼â°¡ °úÀ× »ý»êµÇ¾î Ç×ü·Î¼­ Ç÷·ù ¼Ó¿¡ ¹æÃâµÈ´Ù°í ÇÏ´Â »ý°¢. Ç×ü »ý»êÀÇ ¼±Åü³ÀÇ ÃÖÃÊÀÇ °ÍÀÌ´Ù.
  • Heinz-Ehrlich body
    ÇÏÀÎÁî-¿¡¸¦¸®È÷¼Òü
    Ç÷»ö¼ÒÀÇ »êÈ­ Àå¾Ö¿Í ±× ħÀüÀ¸·Î »ý±ä ±¸»óÀÇ ºÀÀÔü·Î¼­, ¾î¶² Á¾·ùÀÇ ºñÁ¤»ó Ç÷»ö¼Ò ¹× È¿¼Ò °áÇÌ ÀûÇ÷±¸°¡ Á¸ÀçÇÒ ¶§ º¼ ¼ö ÀÖ´Ù. Ç÷¾× µµ¸» Ç¥º»¿¡¼­´Â ±¼Àý¼ºÀ̸ç Romanowsky ¿°»ö¹ýÀ¸·Î´Â ¿°»öµÇÁö ¾Ê°í, ÃÊ»ýü ¿°»ö¹ýÀ¸·Î ¿°»öµÈ´Ù.
  • neutral
    Áß¼ºÀÇ, Á߸³ÀÇ, ÁßÈ­ÀÇ
    È­ÇÐÀûÀ¸·Î »ê¼ºµµ ¾Æ´Ï°í ¿°±â¼ºµµ ¾Æ´Ñ.
  • neutral formaldehyde
    Áß¼º Æ÷¸§ ¾Ëµ¥ÇÏÀ̵å
  • neutral occlusion
    Á¤»ó ±³ÇÕ
    µ¿ÀǾî=normal occlusion.
  • neutral space
    Á߸³°­, Á߸³ °ø°£
  • serum neutral fat
    Ç÷û Áß¼º Áö¹æ
    Ç÷û Áß¼º Áö¹æÀº ´ëºÎºÐÀÌ Æ®¸®±Û¸®¼¼¶óÀ̵åÀ̰í, ±× ³óµµ´Â À½½Ä¹°ÀÇ ¿µÇâÀ» ¹Þ´Â´Ù.
  • acridine orange stain
    ¾ÆÅ©¸®µò ¿À·»Áö ¿°»ö
  • auramine-rhodamine stain
    ¿À¶ó¹Î-·Î´Ù¹Î ¿°»ö
  • Balch's stain
    ¹ßÃ÷ ¿°»ö¾×
    Ç÷¾×µµ¸» Ç¥º»À» ¿°»öÇϴµ¥ »ç¿ëÇÏ´Â Æú¸®Å©·Ò¸ÞÆ¿·»Ã».
  • dopa stain
    µµÆÄ ¿°»ö
  • fluorescent antibody stain
    Çü±¤ Ç×ü ¿°»ö
  • Macchiavello's stain
    ¸¶Å°¾Æº§·Î ¿°»ö
  • Mandelbaum's stain
    ¸¸µ¨¹Ù¿ò ¿°»ö¹ý
    ¸Åµ¶ ±ÕÀÇ »ýü ¿°»ö¹ý.
  • quesnel's stain
    Äù½º³Ú ¿°»ö¾×
    ¿ø½ÂÀ» ¿°»öÇϴµ¥ ¾²ÀÌ´Â ¾×À¸·Î, ¼ö´Ü¥²ÀÇ 80% ¾ËÄÚ¿Ã Æ÷È­¾× 20cc¿Í ¾à¿ë ¸ÞÆ¿·» ûÆ÷È­ ¿©¾× 300cc·Î ÀÌ·ç¾îÁø´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Ehrlich's acid haematoxylin stain <technique> An alum type of haematoxylin stain used as a regressive staining method for nuclei, followed by differentiation to required staining intensity; the solution may be allowed to ripen naturally in sunlight or partially oxidised with sodium iodate.
(05 Mar 2000)
Ehrlich's aniline crystal violet stain <technique> A stain for Gram-positive bacteria.
(05 Mar 2000)
Ehrlich's triacid stain <technique> A differential leukocytic stain comprised of saturated solutions of orange G, acid fuchsin, and methyl green.
(05 Mar 2000)
Ehrlich's triple stain <technique> A mixture of indulin, eosin Y, and aurantia.
(05 Mar 2000)
neutral stain <technique> A compound of an acid stain and a basic stain, such as the eosinate of methylene blue, in which the anion and cation each contains a chromophore group.
Synonym: salt dye.
(05 Mar 2000)
carcinoma, ehrlich tumour A transplantable, poorly differentiated malignant tumour which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
(12 Dec 1998)
Paul Ehrlich <person> A brilliant scientist and student, born in Silesia, Germany, who at the age of 23 published his first scientific paper which was on the discovery of the mast cells - a name coined by him (1887). While a resident in medicine at Charite Hospital in Berlin he utilised the newly discovered aniline dyes to develop some of the basic methods of histology.
Among his contributions are: The preparation and staining of blood smears, he demonstrated granules in leukocytes, described the neutrophil, basophil, eosinophil, myelocyte, and mononuclear cells (white blood cells), he demonstrated normoblasts, megaloblasts and microblasts of the erythrocytic (red blood cell) series.
In 1887, he differentiated lymphocytic leukaemia from "bone marrow leukaemia" (myeloid) on blood smear, in 1888, he described aplastic anaemia, in 1882 the diazo reaction of typhoid urines, in 1882, less than six weeks after Koch described the Tuberculus bacillus, Ehrlich had described its acid-fastness and devised the fuchsin stain to demonstrate the pink rod on a blue background.
Ehrlich fell ill with tuberculosis and went to Egypt for 3 years for rest and cure. Following his return, he entered the field of immunology. at Von Behring's request, he developed means of standardising antitoxin dosage (immunization units).
at the age of 42, he became director of the "Royal Institute for Standardisation and Investigation of Antitoxic Sera." Here he devised his famous "side-chain" theory of immunisation. It has since been replaced.
Paul Ehrlich reinvestigated Bordet's alexin and heat-stable substance and named them "complement" and "immune body". Ehrlich coined the terms and created a new science of chemotherapy.
In 1910 he discovered Salvarsan or 606, a therapeutic antiluetic. For his silver bullet (Salvarsan) in 1908, he received the Nobel Prize. This scientist was greatly concerned over the problem of drug fastness which still remains a problem. He died August 20, 1915.
Lived: 1854-1915.
(18 Nov 1997)
Heinz-Ehrlich body A round oxyphil body found in the red blood cell in case of haemocytolysis due to a specific blood poison.
Synonym: Heinz-Ehrlich body.
(05 Mar 2000)
Ehrlich Paul, German bacteriologist, immunologist, and Nobel laureate, 1854-1915.
See: Ehrlichia, Ehrlich's anaemia, Ehrlich's inner body, Ehrlich's phenomenon, Ehrlich's postulate, Ehrlich's diazo reagent, Ehrlich's theory, Ehrlich-Turk line. See entries under stain; reaction.
(05 Mar 2000)
Ehrlich, Paul <person> A brilliant scientist and student, born in Silesia, Germany, who at the age of 23 published his first scientific paper which was on the discovery of the mast cells - a name coined by him (1887). While a resident in medicine at Charite Hospital in Berlin he utilised the newly discovered aniline dyes to develop some of the basic methods of histology.
Among his contributions are: The preparation and staining of blood smears, he demonstrated granules in leukocytes, described the neutrophil, basophil, eosinophil, myelocyte, and mononuclear cells (white blood cells), he demonstrated normoblasts, megaloblasts and microblasts of the erythrocytic (red blood cell) series.
In 1887, he differentiated lymphocytic leukaemia from "bone marrow leukaemia" (myeloid) on blood smear, in 1888, he described aplastic anaemia, in 1882 the diazo reaction of typhoid urines, in 1882, less than six weeks after Koch described the Tuberculus bacillus, Ehrlich had described its acid-fastness and devised the fuchsin stain to demonstrate the pink rod on a blue background.
Ehrlich fell ill with tuberculosis and went to Egypt for 3 years for rest and cure. Following his return, he entered the field of immunology. at Von Behring's request, he developed means of standardising antitoxin dosage (immunization units).
at the age of 42, he became director of the "Royal Institute for Standardisation and Investigation of Antitoxic Sera." Here he devised his famous "side-chain" theory of immunisation. It has since been replaced.
Paul Ehrlich reinvestigated Bordet's alexin and heat-stable substance and named them "complement" and "immune body". Ehrlich coined the terms and created a new science of chemotherapy.
In 1910 he discovered Salvarsan or 606, a therapeutic antiluetic. For his silver bullet (Salvarsan) in 1908, he received the Nobel Prize. This scientist was greatly concerned over the problem of drug fastness which still remains a problem. He died August 20, 1915.
Lived: 1854-1915.
(18 Nov 1997)
Ehrlich reaction The reaction of the indole derivatives with aromatic aldehydes; e.g., tryptophan and p-dimethylaminobenzaldehyde in H2SO4 give a red-violet colour useful in assaying proteins for tryptophan content.
Synonym: Ehrlich reaction.
(05 Mar 2000)
Ehrlich's anaemia <haematology> This form of anaemia occurs when the bone marrow ceases sufficient red and white blood cell production. It may be induced by exposures to high levels of toxic chemicals, radiation and certain drugs.
It is generally unresponsive to specific therapy, often accompanied by granulocytopenia and thrombocytopenia, in which the bone marrow may not necessarily be hypocellular or hypoplastic but fails to produce adequate numbers of peripheral blood elements. The term actually is all inclusive and most probably encompasses several clinical syndromes.
Origin: Gr. Haima = blood
(29 Sep 1997)
Ehrlich's benzaldehyde reaction A test for urobilinogen in the urine, by dissolving 2 g of dimethyl-p-aminobenzaldehyde in 100 ml of 5% hydrochloric acid and adding this reagent to urine; a red colour in the cold indicates the presence of an excessive amount of urobilinogen.
(05 Mar 2000)
Ehrlich's diazo reaction The reaction of diazotised sulfanilic acid with bilirubin to form azobilirubin, which forms the basis of quantitating the amount of bilirubin in biological fluids.
See: van den Bergh's test.
Synonym: Ehrlich's diazo reaction.
(05 Mar 2000)
Ehrlich's diazo reagent Two solutions, one of sodium nitrite, the other of acidified sulfanilic acid, used in bringing about diazotization.
Synonym: Ehrlich's diazo reagent.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • stain
    À» ´õ·´È÷´Ù
  • stain
    ¾ó·èÀ» ¹¯È÷´Ù;´õ·´È÷´Ù;(¸í¿¹¸¦)¼Õ»ó½ÃŰ´Ù;(À¯¸® µûÀ§¿¡)Âø»öÇÏ´Ù;´õ·¯¿öÁö´Ù;¾ó·èÁö´Ù;¾ó·è;Èì;¿ÀÁ¡;Âø»ö(Á¦)
  • neutral
    Á߸³ÀÇ
  • Idiom Neutral
    À̵ð¾ö ´ºÆ®·²(1902³â¿¡ ¹ßÇ¥µÈ ÀΰøÀû ±¹Á¦ º¸Á¶¾î)
  • neutral
    Á߸³(±¹)ÀÇ;Á߸³±¹;ºÒÆíºÎ´çÀÇ;¾î´ÀÆíµµ µéÁö ¾Ê´Â;(Á¾·ù,Ư¡)ºÐ¸íÄ¡ ¾ÊÀº;(»öÀÌ)¹Ù·£;ȸ»öÀÇ;Áß¼ºÀÇ;¾Ï¼ö ±¸º°ÀÌ ¾ø´Â;(ÇôÀÇ À§Ä¡°¡)Áß¼ºÀÇ;Áß°£ÀÇ;Á߸®±¹(¹Î);Á߸³ÀÚ;(Àüµ¿±â¾îÀÇ)Á߸³(À§Ä¡)
  • neutral corner
    ´ºÆ®·² ÄÚ³Ê(°æ±âÀÚÀÇ ÈÞ°Ô¿ëÀ¸·Î ÁöÁ¤µÇ¾î ÀÖÁö ¾ÊÀº ÄÚ³Ê)
  • neutral current
    Á߸³Àû ¼Ò¸³ÀÚ·ù;Áß¼º Ä¿·»Æ®
  • neutral meson
    Áß¼º Áß°£ÀÚ(neutretto)
  • neutral mutation
    Á߸³µ¹¿¬º¯ÀÌ
  • neutral spirits
    Áß¼º ÁÖÁ¤(95µµ ÀÌ»ó¼ø¼ö ¾ËÄÚ¿Ã,º¸Åë ´Ù¸¥ ¼ú°ú ¼¯¾î¸¶½É)
  • neutral tint
    Áß°£»ö;¿¬ÇÑȸ»ö
  • neutral zone
    Áß°£Áö´ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á